By Megan McCarthy
Neuroimaging is changing the way clinicians study and treat dementia, and the University of Pennsylvania is now better positioned to train the next generation of researchers in this field.
Corey McMillan, PhD, research director of the Penn Frontotemporal Degeneration Center and principle investigator (PI) of the BiND Lab, will be the program director of a newly funded T32 Predoctoral and Postdoctoral Training Program on Translational Neuroimaging in Alzheimer’s Disease and Related Dementia (ADRD) to support five trainees. Alongside Dr. McMillan, co-directors and co-PIs include John Detre, MD, and Murray Grossman, MD, EdD.
A two-year fellowship, this is designed for trainees to develop a research career focused on neuroimaging in ADRD.
“Neuroimaging has become a leading strategy used for translational research in Alzheimer’s disease and related dementias (ADRD) that can be used to improve diagnosis, prognosis, and evaluating efficacy of clinical trials,” said Dr. McMillan, who also co-leads the Genomics Core of the Penn Alzheimer’s Disease Research Center (ADRC).